Post-approval Study of NovoTTF-100A in Recurrent GBM Patients

Clinical Trial ID NCT01756729

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01756729

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 2012 3.66
2 Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci U S A 2007 2.64
3 Disruption of cancer cell replication by alternating electric fields. Cancer Res 2004 2.62
Next 100